These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

91 related items for PubMed ID: 1540839

  • 1. Racemized D-aspartate in Alzheimer neurofibrillary tangles.
    Fisher GH, Payan IL, Chou SJ, Man EH, Cerwinski S, Martin T, Emory C, Frey WH.
    Brain Res Bull; 1992 Jan; 28(1):127-31. PubMed ID: 1540839
    [Abstract] [Full Text] [Related]

  • 2. Altered aspartate in Alzheimer neurofibrillary tangles.
    Payan IL, Chou SJ, Fisher GH, Man EH, Emory C, Frey WH.
    Neurochem Res; 1992 Feb; 17(2):187-91. PubMed ID: 1531702
    [Abstract] [Full Text] [Related]

  • 3. Detection of D-aspartate in tau proteins associated with Alzheimer paired helical filaments.
    Kenessey A, Yen SH, Liu WK, Yang XR, Dunlop DS.
    Brain Res; 1995 Mar 27; 675(1-2):183-9. PubMed ID: 7796127
    [Abstract] [Full Text] [Related]

  • 4. Quantification of D-aspartate in normal and Alzheimer brains.
    Fisher GH, D'Aniello A, Vetere A, Cusano GP, Chávez M, Petrucelli L.
    Neurosci Lett; 1992 Aug 31; 143(1-2):215-8. PubMed ID: 1436669
    [Abstract] [Full Text] [Related]

  • 5. Drastic neuronal loss in vivo by beta-amyloid racemized at Ser(26) residue: conversion of non-toxic [D-Ser(26)]beta-amyloid 1-40 to toxic and proteinase-resistant fragments.
    Kaneko I, Morimoto K, Kubo T.
    Neuroscience; 2001 Aug 31; 104(4):1003-11. PubMed ID: 11457586
    [Abstract] [Full Text] [Related]

  • 6. Progressive neuronal DNA damage associated with neurofibrillary tangle formation in Alzheimer disease.
    Sheng JG, Mrak RE, Griffin WS.
    J Neuropathol Exp Neurol; 1998 Apr 31; 57(4):323-8. PubMed ID: 9600224
    [Abstract] [Full Text] [Related]

  • 7.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 8.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 9. Altered phosphorylation of growth-associated protein B50/GAP-43 in Alzheimer disease with high neurofibrillary tangle density.
    Martzen MR, Nagy A, Coleman PD, Zwiers H.
    Proc Natl Acad Sci U S A; 1993 Dec 01; 90(23):11187-91. PubMed ID: 8248225
    [Abstract] [Full Text] [Related]

  • 10. Beta-amyloid racemized at the Ser26 residue in the brains of patients with Alzheimer disease: implications in the pathogenesis of Alzheimer disease.
    Kubo T, Kumagae Y, Miller CA, Kaneko I.
    J Neuropathol Exp Neurol; 2003 Mar 01; 62(3):248-59. PubMed ID: 12638729
    [Abstract] [Full Text] [Related]

  • 11. Mechanism of Alzheimer neurofibrillary degeneration and the formation of tangles.
    Iqbal K, Grundke-Iqbal I.
    Mol Psychiatry; 1997 May 01; 2(3):178-80. PubMed ID: 9152977
    [No Abstract] [Full Text] [Related]

  • 12. Pseudophosphorylation of tau at serine 422 inhibits caspase cleavage: in vitro evidence and implications for tangle formation in vivo.
    Guillozet-Bongaarts AL, Cahill ME, Cryns VL, Reynolds MR, Berry RW, Binder LI.
    J Neurochem; 2006 May 01; 97(4):1005-14. PubMed ID: 16606369
    [Abstract] [Full Text] [Related]

  • 13. Early AGEing and Alzheimer's.
    Smith MA, Sayre LM, Vitek MP, Monnier VM, Perry G.
    Nature; 1995 Mar 23; 374(6520):316. PubMed ID: 7885469
    [No Abstract] [Full Text] [Related]

  • 14. The role of neurofibrillary tangles in Alzheimer disease.
    Brion JP.
    Acta Neurol Belg; 1998 Jun 23; 98(2):165-74. PubMed ID: 9686275
    [Abstract] [Full Text] [Related]

  • 15. Ubiquitin expression in globose tangles in the locus coeruleus in brains of patients with Alzheimer's and Parkinson's diseases.
    Kida E, Barcikowska M.
    Neurosci Lett; 1992 Feb 17; 136(1):59-62. PubMed ID: 1321968
    [Abstract] [Full Text] [Related]

  • 16. Direct determination of the proportion of intra- and extra-cellular neocortical neurofibrillary tangles in Alzheimer's disease.
    Vickers JC, Tan A, Dickson TC.
    Brain Res; 2003 May 02; 971(1):135-7. PubMed ID: 12691846
    [Abstract] [Full Text] [Related]

  • 17. Isoaspartate formation at position 23 of amyloid beta peptide enhanced fibril formation and deposited onto senile plaques and vascular amyloids in Alzheimer's disease.
    Shimizu T, Fukuda H, Murayama S, Izumiyama N, Shirasawa T.
    J Neurosci Res; 2002 Nov 01; 70(3):451-61. PubMed ID: 12391606
    [Abstract] [Full Text] [Related]

  • 18. Carbonyl-related posttranslational modification of neurofilament protein in the neurofibrillary pathology of Alzheimer's disease.
    Smith MA, Rudnicka-Nawrot M, Richey PL, Praprotnik D, Mulvihill P, Miller CA, Sayre LM, Perry G.
    J Neurochem; 1995 Jun 01; 64(6):2660-6. PubMed ID: 7539057
    [Abstract] [Full Text] [Related]

  • 19. Presence of D-alanine in proteins of normal and Alzheimer human brain.
    D'Aniello A, Vetere A, Fisher GH, Cusano G, Chavez M, Petrucelli L.
    Brain Res; 1992 Oct 02; 592(1-2):44-8. PubMed ID: 1450921
    [Abstract] [Full Text] [Related]

  • 20. [Apolipoprotein B immunoreactivity in cerebral amyloid deposits and neurofibrillary tangles in senile dementia of Alzheimer type].
    Namba Y, Ikeda K.
    Rinsho Shinkeigaku; 1991 Aug 02; 31(8):826-30. PubMed ID: 1764857
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 5.